Christopher Gannatti and Samuel Rines show how next-gen firms are turning Europe into a digital stronghold, and how the WisdomTree Europe Defense Fund (WDEF) gives investors direct access to this long ...

Christopher Gannatti recaps a recent episode of The Next Big Thing podcast, where our thought leaders sat down with Rheinmetall’s Dirk Winkels to explore how the company is reshaping European defense.

Behnood Noei shows how the WisdomTree Inflation Plus Fund’s multi-asset strategy seeks to offer a more adaptable, risk-aware path forward.

Gold surged in early 2025 as investors sought protection against long-term fiscal instability, yet its lack of income generation raises important opportunity cost concerns, especially when it replaces ...

In today’s advisor landscape, making a polished digital presence is critical to earning trust. Organic growth has shifted from word of mouth to web-first impressions, requiring advisors to align their ...

Ryan Krystopowicz makes the case for WisdomTree’s Shared CIO: a custom model platform that delivers institutional rigor, true personalization and seamless scalability, without sacrificing control.

Christopher Gannatti and Jeremy Schwartz argue that while history favors equities for long-term growth, 2025’s shifting macro backdrop makes a compelling case for gold and shows how WisdomTree’s ...

ETFs (Exchange-Traded Funds) are securities traded on stock exchanges, representing a basket of assets like stocks, bonds, or commodities, and typically track an index such as the S&P 500. ETFs offer ...

The U.S. Treasury (UST) 10-year yield could trend toward 5% in 2025, supported by a combination of historical averages and a steepening Treasury yield curve. While inflation improvements remain uneven ...

Exchange-traded funds are at least as liquid as their underlying basket, and there is a now a more accurate way for them to be measured.

After years of underwhelming performance, biotech may finally be ready for a breakthrough in 2025. Chris Gannatti highlights how advancements in gene editing, AI-driven drug discovery and policy ...

Samuel Rines exhibits a positive outlook for the U.S. consumer based on the performance of companies like Costco, Ross Stores and Constellation Brands.